Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Percutaneous Ultrasound-guided "Three-step" Radiofrequency Ablation for Giant Hepatic Hemangioma: a Safe, Feasible and Effective New Technology

NCT04131153 is registered in ClinicalTrials.gov with Southwest Hospital, China as lead sponsor.

NCT NCT04131153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04131153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Percutaneous Ultrasound-guided "Three-step" Radiofrequency Ablation for Giant Hepatic Hemangioma: a Safe, Feasible and Effective New Technology
Lead sponsor
Southwest Hospital, China
Phase
Not applicable
Overall status
Completed
Start date
June 1, 2013
Completion date
August 1, 2019
Enrollment
106 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hepatic hemangioma